✦ LIBER ✦

Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide

✍ Scribed by Eun Joo Chung; Won Tae Yoon; Ji-Youn Kim; Won Yong Lee

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 102 KB
Volume: 21
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twice-daily, low-dose pramipexole in ear

Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial

✍ Karl Kieburtz; The Parkinson Study Group PramiBID Investigators 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, double‐blind, placebo controlled trial involving 311 early PD patients not receiving dopaminer

Valvular heart disease in Parkinson's di

Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study

✍ Susann Junghanns; Joerg T. Fuhrmann; Gregor Simonis; Christian Oelwein; Rainer K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract Fibrotic valvular heart disease (VHD) has been reported in association with ergot dopamine agonists (DAs), but the current database is insufficient regarding clinical relevance and comparison to data on non‐ergot DAs. We evaluated the effects of four DAs (pergolide, cabergoline, ropinir

Fatal bleomycin toxicity from a low cumu

Fatal bleomycin toxicity from a low cumulative dose in a patient with renal insufficiency

✍ Beverly F. McLeod; H. Jeffrey Lawrence; David W. Smith; Phillip J. Vogt; David R 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

Low-dose naltrexone for treatment of duo

Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient

✍ Angela Shannon; Naim Alkhouri; Shadi Mayacy; Barbara Kaplan; Lori Mahajan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Randomized study of sertraline and low-d

Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life

✍ Angelo Antonini; Silvana Tesei; Anna Zecchinelli; Paolo Barone; Danilo De Gaspar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

We assessed the effect of 3-month treatment of sertraline (50 mg) or low-dose amitriptyline (25 mg) on depression and quality of life in 31 patients with Parkinson's disease in a prospective single-blind randomized study. Both drugs significantly reduced the Hamilton Depression Rating Scale (HDRS-17

First emergence of “delayed-on” and “dos

First emergence of “delayed-on” and “dose failure” phenomena in a patient with Parkinson's disease following vagotomy

✍ Ruth Djaldetti; Anat Achiron; Ilan Ziv; Eldad Melamed 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Complex response fluctuations represent a major complication of chronic levodopa therapy in patients with Parkinson's disease. Of those, the "wearing off' and "on-off'' phenomena are more widely recognized (1). However, two other subtypes of motor fluctuations, i.e., "delayed-on'' (increased latency